Answer
Parsabiv (etelcalcetide hydrochloride) treats secondary hyperparathyroidism in adults with chronic kidney disease receiving haemodialysis.
Sources for this answer
- ParsabivAmgen Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 7Document updated
Sources checked